LUMID

Welcome to the Brand page for “LUMID”, which is offered here for Drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, clinical trials; research and development of new products; pharmaceutical, scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell;.

Its status is currently believed to be active. Its class is unavailable. “LUMID” is believed to be currently owned by “SEED Therapeutics US, Inc.”